Predictive genetic testing in maturity-onset diabetes of the young (MODY).
about
Monogenic diabetes and pregnancyGenetic linkage of hyperglycemia and dyslipidemia in an intercross between BALB/cJ and SM/J Apoe-deficient mouse strains.New quantitative trait loci for carotid atherosclerosis identified in an intercross derived from apolipoprotein E-deficient mouse strains.Genetic analysis of atherosclerosis and glucose homeostasis in an intercross between C57BL/6 and BALB/cJ apolipoprotein E-deficient mice.Polygenic risk variants for type 2 diabetes susceptibility modify age at diagnosis in monogenic HNF1A diabetes.Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes.The impact of patents on the development of genome-based clinical diagnostics: an analysis of case studies.Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes.High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.Clinical features and treatment of maturity onset diabetes of the young (MODY).Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.Predictive or not predictive: understanding the mixed messages from the patient's DNA sequence.A novel mutation in the hepatocyte nuclear factor-1β gene in maturity onset diabetes of the young 5 with multiple renal cysts and pancreas hypogenesis: A case report.Quality in genetic counselling for presymptomatic testing--clinical guidelines for practice across the range of genetic conditions.Inhibition of hepatocyte nuclear factor 1 and 4 alpha (HNF1α and HNF4α) as a mechanism of arsenic carcinogenesis.Clinical utility gene card for: Maturity-onset diabetes of the young.Type 2 diabetes mellitus and its complications: from the molecular biology to the clinical practice.Genetic counseling: a survey to explore knowledge and attitudes of Italian nurses and midwives.Functional Investigations of HNF1A Identify Rare Variants as Risk Factors for Type 2 Diabetes in the General Population.Ethical issues in presymptomatic genetic testing for minors: a dilemma in Li-Fraumeni syndrome.Maturity onset diabetes of young type 2 due to a novel de novo GKC mutation.
P2860
Q28066434-53FB3D63-71BB-47A5-B5D2-93D8246637E9Q30278356-7BE66102-568C-439E-A5D0-7C07E9C5A0A4Q30413841-38F22DE9-048D-4524-A958-D09EE95328CDQ30421525-72625BEB-92F3-4770-B3A1-DB8AE951A38EQ33556591-A94759AB-4B9C-40D4-AADD-041823DED88AQ33734037-403C40FD-0475-41EB-97DD-E3DFBC89C1BFQ33865988-31928B9C-653D-4242-B0D5-80500F032448Q34569347-275B3A01-3339-41B5-9188-2584FE9002F8Q35123336-A7FA81D0-9370-4080-827E-28FF1C4DC680Q35997281-1801D152-40E5-4007-96DA-BAFACACA83AEQ36501677-FB329F47-8050-45C4-9CCF-150B933F18D8Q38945647-C2C695DA-FC75-4C46-983E-A6A71221F483Q41623705-A18B5EEB-25B5-4BC1-9F22-E5BEFECE4E94Q42237704-3BFC1DC3-AA84-4D2D-B128-940F7A88A27CQ42715413-E1A67E68-2DD4-4AD6-ADC3-5DE8E83FD577Q42796379-B6A4E27B-1E51-44A2-A3FF-BE4B0460B7B3Q42976561-F8DE2ADC-6B7A-4B2F-B0C6-76B67C06A1C8Q44534606-773F9774-7C5B-4C8A-935C-BC9AC7115D87Q48190008-B46F3E56-3165-4BA3-9EBF-DFF27146159DQ48338215-3FB37443-8570-4A86-B883-049FCCAFC86FQ51313214-D2456609-C7A6-4505-B1BD-C7E47A003EDA
P2860
Predictive genetic testing in maturity-onset diabetes of the young (MODY).
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Predictive genetic testing in maturity-onset diabetes of the young (MODY).
@en
type
label
Predictive genetic testing in maturity-onset diabetes of the young (MODY).
@en
prefLabel
Predictive genetic testing in maturity-onset diabetes of the young (MODY).
@en
P2093
P2860
P1433
P1476
Predictive genetic testing in maturity-onset diabetes of the young (MODY).
@en
P2093
A C Sparkes
A T Hattersley
D Bowen-Jones
M Shepherd
P2860
P304
P356
10.1046/J.1464-5491.2001.00447.X
P50
P577
2001-05-01T00:00:00Z